OCS Liver PROTECT Continuation Post-Approval Study
NCT05096741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-01-09
Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
Conditions
- Liver Transplant
Interventions
- DEVICE
-
OCS Liver
Transplanted with a OCS preserved liver
Sponsors & Collaborators
-
TransMedics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-24
- Primary Completion
- 2021-11-05
- Completion
- 2021-11-05
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over
NCT04754503 ·Status: UNKNOWN
-
Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
NCT07301853 ·Status: RECRUITING
-
Covid Vaccination in Liver Transplantation
NCT05079165 ·Status: UNKNOWN
-
Liver Transplantation After ex Vivo Liver Perfusion
NCT05951231 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation
NCT02515708 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant
NCT05916495 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors
NCT03676361 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Feasibility Study of Octreotide Infusion During Liver Transplant.
NCT04941911 ·Status: UNKNOWN ·Phase: PHASE2
-
International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation
NCT01630434 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
NCT03702218 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study
NCT04057001 ·Status: TERMINATED
-
Impact of a Risk Stratification Tool on the Outcome of Liver Transplant Recipients Colonized With Carbapenem Resistant Enterobacteriaceae: an Observational Study
NCT05594901 ·Status: ACTIVE_NOT_RECRUITING
-
Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR
NCT06542913 ·Status: NOT_YET_RECRUITING
-
Hepatic Transplantation Registry
NCT05944042 ·Status: RECRUITING
-
Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation
NCT06169592 ·Status: RECRUITING
-
Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
NCT05793203 ·Status: RECRUITING
-
Intraoperative "p50" Measurement in Liver Transplant Surgeries
NCT06660095 ·Status: ENROLLING_BY_INVITATION
-
Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
NCT02995096 ·Status: COMPLETED
-
A Retrospective Review of Infections Usually Observed in Transplant Recipients
NCT00298077 ·Status: COMPLETED
-
COVID-19 in Liver Transplant Recipients
NCT04361591 ·Status: COMPLETED
-
Association of Genetic Polymorphism and Acute Kidney Injury After Liver Transplantation
NCT02489474 ·Status: COMPLETED
-
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
NCT03627299 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers
NCT00857844 ·Status: COMPLETED
-
Renal Failure Following Lung Transplantation in Cystic Fibrosis Patients
NCT05001841 ·Status: COMPLETED
-
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
NCT03639025 ·Status: ACTIVE_NOT_RECRUITING